Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philipp Steiner

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Cancer Immunology Research|March 14, 2022
Discovery of a Conditionally Activated IL-2 that Promotes Antitumor Immunity and Induces Tumor RegressionChristopher J Nirschl, Heather R Brodkin, Daniel J Hicklin, et al.
Cancer Immunology Research|April 19, 2023
mWTX-330, an IL-12 INDUKINE Molecule, Activates and Reshapes Tumor-Infiltrating CD8+ T and NK Cells to Generate Antitumor ImmunityChristopher J Nirschl, Heather R Brodkin, Celesztina Domonkos, et al.
Molecular Cancer Therapeutics|February 17, 2016
A Potent HER3 Monoclonal Antibody That Blocks Both Ligand-Dependent and -Independent Activities: Differential Impacts of PTEN Status on Tumor ResponseZhan Xiao, Rosa A Carrasco, Kevin Schifferli, et al.
Cancer Treatment and Research Communications|July 17, 2021
Characterization of ASP8374, a fully-human, antagonistic anti-TIGIT monoclonal antibodyKenna Shirasuna, Gerald Koelsch, Cynthia Seidel-Dugan, et al.
Molecular Cancer Therapeutics|March 16, 2005
Targeting the platelet-derived growth factor receptor alpha with a neutralizing human monoclonal antibody inhibits the growth of tumor xenografts: implications as a potential therapeutic targetNick Loizos, Yan Xu, Jim Huber, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Cancer Immunology Research|March 14, 2022
Discovery of a Conditionally Activated IL-2 that Promotes Antitumor Immunity and Induces Tumor RegressionChristopher J Nirschl, Heather R Brodkin, Daniel J Hicklin, et al.
Cancer Immunology Research|April 19, 2023
mWTX-330, an IL-12 INDUKINE Molecule, Activates and Reshapes Tumor-Infiltrating CD8+ T and NK Cells to Generate Antitumor ImmunityChristopher J Nirschl, Heather R Brodkin, Celesztina Domonkos, et al.
Molecular Cancer Therapeutics|February 17, 2016
A Potent HER3 Monoclonal Antibody That Blocks Both Ligand-Dependent and -Independent Activities: Differential Impacts of PTEN Status on Tumor ResponseZhan Xiao, Rosa A Carrasco, Kevin Schifferli, et al.
Cancer Treatment and Research Communications|July 17, 2021
Characterization of ASP8374, a fully-human, antagonistic anti-TIGIT monoclonal antibodyKenna Shirasuna, Gerald Koelsch, Cynthia Seidel-Dugan, et al.
Molecular Cancer Therapeutics|March 16, 2005
Targeting the platelet-derived growth factor receptor alpha with a neutralizing human monoclonal antibody inhibits the growth of tumor xenografts: implications as a potential therapeutic targetNick Loizos, Yan Xu, Jim Huber, et al.
Pageof 2